A clinical trail to study the Efficacy and Safety of Cervispon Capsule in the management of Cervical Spondylosis

Efficacy and Safety of Cervispon Capsule in the management of Cervical Spondylosis: A Randomized double blind pilot study.

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056725

Enrollment

Registered

2023-08-22

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G09- Sequelae of inflammatory diseasesof central nervous system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Either gender of above 18 years of age 2. Subjects meeting with diagnostic criteria for Cervical Spondylitis 3. Subjects who are willing to sign informed consent for participation in the study

Exclusion criteria

Exclusion criteria: 1. Pregnant women and lactating women are excluded from the study. 2. Subjects with significant and uncontrolled hematological /metabolic/ endocrinologial/ respiratory/ cardiovascular/ neurological/psychiatric/liver/ gastrointestinal/kidney diseases or other significant pathological conditions which is judged by Investigator may affect the subject participation in the study

Design outcomes

Primary

Measure	Time frame
The effectivesness of cervispon capsule will be determined.Timepoint: Baseline and after 12 weeks	—

Secondary

Measure	Time frame
The safety of cervispon capsule will be determined.Timepoint: Baseline, 30th day, 60th day and 90th day	—

Countries

India

Contacts

Public ContactDr Jagadeesan M

SRM Medical College Hospital and Research Center

vijayanb@srmist.edu.in

Outcome results